Evidence map›Paper›PMID 35434262›Full record

ArticleInformatics in medicine unlocked2022

Supervised learning of COVID-19 patients' characteristics to discover symptom patterns and improve patient outcome prediction.

Sadegh Ilbeigipour, Amir Albadvi

Abstract read
In one paragraph

Article in Informatics in medicine unlocked, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sadegh IlbeigipourDepartment of Information Technology Engineering, Industrial and Systems Engineering Faculty, Tarbiat Modares University, Tehran, Iran.
Amir AlbadviDepartment of Information Technology Engineering, Industrial and Systems Engineering Faculty, Tarbiat Modares University, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The world today faces a new challenge that is unprecedented in the last 100 years. The emergence of a new coronavirus has led to a human catastrophe. Scientists in various sciences have been looking for solutions to this problem so far. In addition to general vaccination, maintaining social distance and adherence to government guidelines on safety precaution measures are the most well-known strategies to prevent COVID-19 infection. In this research, we tried to examine the symptoms of COVID-19 cases through different supervised machine learning methods. We solved the class imbalance problem using the synthetic minority over-sampling (SMOTE) method and then developed some classification models to predict the outcome of COVID-19 cases (recovery or death). Besides, we implemented a rule-based technique to identify different combinations of variables with specific ranges of their values that together affect disease severity. Our results showed that the random forest model with 95.6% accuracy, 97.1% sensitivity, 94.0% specification, 94.4% precision, 95.8% F-score, and 99.3% AUC-score outperforms state-of-the-art classification models. Finally, we identified the most significant rules that state various combinations of 6 features in certain ranges of their values lead to patients' recovery with a confidence value of 90%. In conclusion, the classification results in this study show better performance than recent studies, and the extracted rules help physicians consider other important factors to improve health services and medical decision-making for different groups of COVID-19 patients.

Indexed as

Association rules miningConfidence indexCOVID-19Machine learningSupervised learningSupport index

Identifiers

PMID35434262
PMCPMC9004256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.